SignatureFD’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

SignatureFD’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3	Closed	–	–	2820
2020 Q2	$0	Buy	+3	New	+$202	﹤0.01%	2726

Other funds holding EVFM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SignatureFD's EVFM Position: Q3 2020 in Review

SignatureFD sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2020, closing a stake of 3 shares.

SignatureFD first reported a position in EVFM in Q2 2020 and held it in 1 quarter. The position peaked at $0 in Q2 2020. 99 funds tracked by Wall St. Rank hold EVFM as of Q3 2020.

SignatureFD reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
SignatureFD sold 3 Evofem Biosciences, Inc. Common Stock shares in Q3 2020.
SignatureFD first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
SignatureFD's Evofem Biosciences, Inc. Common Stock position peaked at $0 in Q2 2020.
99 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2020.

Based on SignatureFD's 13F filing for Q3 2020, filed 3 Nov 2020.